GERN Insider Trading

Insider Ownership Percentage: 3.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $6,808,003.88

Geron Insider Trading History Chart

This chart shows the insider buying and selling history at Geron by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$2M$0$2MTotal Insider BuyingTotal Insider Selling

Geron Share Price & Price History

Current Price: $2.89
Price Change: Price Decrease of -0.03 (-1.03%)
As of 01/17/2025 05:00 PM ET

This chart shows the closing price history over time for GERN up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
FebMarAprMayJunJulAugSepOctNovDecJan$2.89Closing price on 01/20/25:

SEC Filings (Institutional Ownership Changes) for Geron (NASDAQ:GERN)

73.71% of Geron stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at GERN by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$652kbought$124ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$200M$0$200MTotal InflowsTotal Outflows
Geron logo
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Read More on Geron

Today's Range

Now: $2.89
Low: $2.85
High: $2.99

50 Day Range

MA: $3.65
Low: $2.89
High: $4.17

52 Week Range

Now: $2.89
Low: $1.64
High: $5.34

Volume

8,637,921 shs

Average Volume

12,673,040 shs

Market Capitalization

$1.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.55

Who are the company insiders with the largest holdings of Geron?

Geron's top insider shareholders include:
  1. John A Scarlett (CEO)
  2. Olivia Kyusuk Bloom (CFO)
  3. Elizabeth G O'farrell (Director)
  4. Andrew J Grethlein (COO)
  5. Faye Feller (EVP)
  6. John A Scarlett (CEO)
  7. Susan Molineaux (Director)
  8. V Bryan Lawlis (Director)
Learn More about top insider investors at Geron.

Who are the major institutional investors of Geron?

Geron's top institutional investors include:
  1. Hennion & Walsh Asset Management Inc. — 0.07%
  2. Moody National Bank Trust Division — 0.04%
  3. Inspire Investing LLC — 0.02%
  4. Elmwood Wealth Management Inc. — 0.00%
  5. Monterey Private Wealth Inc. — 0.00%
  6. Rovin Capital UT ADV — 0.00%
Learn More about top institutional investors of Geron stock.

Which major investors are selling Geron stock?

Within the last quarter, GERN stock was sold by these institutional investors:
  1. Inspire Investing LLC
In the previous year, company insiders that have sold Geron company stock include:
  1. John A Scarlett (CEO)
  2. Olivia Kyusuk Bloom (CFO)
  3. Elizabeth G O'farrell (Director)
Learn More investors selling Geron stock.

Which major investors are buying Geron stock?

During the previous quarter, GERN stock was acquired by institutional investors including:
  1. Moody National Bank Trust Division
  2. Hennion & Walsh Asset Management Inc.
  3. Elmwood Wealth Management Inc.
  4. Monterey Private Wealth Inc.
  5. Rovin Capital UT ADV